From: | Becker's Spine Review <editorial@beckershealthcare.com> |
Subject: | J&J reports declining spine sales in Q3 - what to expect in Q4 | Sutter Health destroys evidence in antitrust case over inflated prices | Highmark 1st private payer with exclusive coverage for Paradigm's coflex: 5 highlights | Medtronic CEO Omar Ishrak: 5 key points on the future of value-based care for device companies |
Preheader: | |
Reply: | editorial@beckershealthcare.com |
|